This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 May 1;37(13):1041-1043.

doi: 10.1200/JCO.19.00056. Epub 2019 Mar 12.

Targeting Stroma: A Tale of Caution

Andrea Wang-Gillam¹

Affiliations

PMID: 30860950
DOI: 10.1200/JCO.19.00056

Editorial

Targeting Stroma: A Tale of Caution

Andrea Wang-Gillam. J Clin Oncol. 2019.

. 2019 May 1;37(13):1041-1043.

doi: 10.1200/JCO.19.00056. Epub 2019 Mar 12.

Author

Andrea Wang-Gillam¹

Affiliation

¹ 1 Washington University in St Louis, St Louis, MO.

PMID: 30860950
DOI: 10.1200/JCO.19.00056

No abstract available

PubMed Disclaimer

Comment on

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.
Ramanathan RK, McDonough SL, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, Thumar J, Chiorean EG, Shields AF, Behl D, Mehan PT, Gaur R, Seery T, Guthrie KA, Hochster HS. Ramanathan RK, et al. J Clin Oncol. 2019 May 1;37(13):1062-1069. doi: 10.1200/JCO.18.01295. Epub 2019 Feb 28. J Clin Oncol. 2019. PMID: 30817250 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information